Hansen’s disease rheumatic manifestations represent a significant yet often overlooked clinical aspect of leprosy. While cutaneous and neurological symptoms are the primary hallmarks, musculoskeletal involvement remains the third most common feature. A recent study from Puerto Rico highlights the necessity of using a standardized approach to identify these features, which frequently mimic common idiopathic autoimmune conditions.

Clinical Presentation and Common Patterns

Rheumatic involvement in leprosy can manifest during any stage of the infection. In many instances, patients present with symmetrical polyarthritis that closely resembles rheumatoid arthritis (RA). This clinical similarity often leads to significant diagnostic delays, especially in regions where leprosy is less prevalent. Additionally, clinicians frequently observe tenosynovitis, dactylitis, and the characteristic \"swollen hands and feet syndrome\" among affected individuals.

Managing Hansen's Disease Rheumatic Manifestations

Distinguishing leprosy from other rheumatic diseases is vital because management strategies differ fundamentally. For instance, the use of immunosuppressive biologics for a misdiagnosed case of RA could potentially exacerbate an underlying Mycobacterium leprae infection. Therefore, clinicians should prioritize the identification of cardinal signs, such as anesthetic skin patches and thickened peripheral nerves. Furthermore, laboratory markers like anti-cyclic citrullinated peptide (anti-CCP) antibodies are highly useful. While Rheumatoid Factor (RF) is often positive in leprosy patients, anti-CCP remains exceptionally specific for RA.

The Impact of Lepra Reactions

Most acute rheumatic symptoms occur during the course of lepra reactions. Type 1 (reversal) reactions typically involve acute neuritis alongside joint swelling. Conversely, Type 2 reactions, or Erythema Nodosum Leprosum (ENL), often present with painful subcutaneous nodules and systemic inflammatory symptoms. Early recognition of these reactional states ensures that patients receive appropriate multi-drug therapy (MDT) and anti-inflammatory care to prevent permanent disability.

Frequently Asked Questions

How does leprosy-associated arthritis differ from rheumatoid arthritis?

Leprosy-associated arthritis generally lacks the aggressive erosive radiological changes seen in RA. Additionally, leprosy patients usually exhibit neuro-cutaneous signs and are typically negative for anti-CCP antibodies, even if their Rheumatoid Factor test is positive.

Are the rheumatic symptoms in Hansen's disease permanent?

Most acute rheumatic features resolve with effective multi-drug therapy and corticosteroids during lepra reactions. However, if chronic joint involvement is left untreated, it may lead to secondary musculoskeletal deformities and long-term morbidity.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a substitute for professional healthcare consultation. Refer to the latest local and national guidelines for clinical practice.

References

1. Vilá LM et al. Characterization of Rheumatic Manifestations in Hansen's Disease: A Standardized Approach among Patients from Puerto Rico. Am J Trop Med Hyg. 2026 Feb 24. doi: undefined. PMID: 41734397.


2. Sarka RN et al. Musculoskeletal involvement in leprosy. Indian Journal of Rheumatology. 2011; 6(1): 20-24.


3. Dionello CF et al. New insights at the interface between leprosy and immune-mediated rheumatic diseases. Frontiers in Medicine. 2023 Sep 24.